跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

PharmaPendium 支持药物安全性和有效性决策,以获得更好的药物结果

您需要高质量的数据来充满信心地发现、创新和开发。PharmaPendium 将无与伦比的监管和药物数据与全文搜索和预测工具相结合。使用 PharmaPendium 减少动物试验并更快地推出药物。

Women in white lab coats looking at computer screen

被 FDA 和世界顶级制药公司使用

获得关键见解,尽早预测候选药物的成功或失败

Video overview of PharmaPendium

Watch now

|

为了推进最佳候选药物,您需要证明更好的性能。PharmaPendium 具有用户友好的工具,可帮助您分析安全性、可交付性和疗效数据。

  • 自信地预测药物间相互作用

  • 预测脱靶药物不良反应的风险(安全裕度

  • 通过跨临床前、临床和上市后的转化视图访问数据,包括:

    • 临床前和临床安全性

    • 动物模型

    • 不良事件 (MedDRA)

    • 药代动力学参数

    • 代谢和运输

    • 临床试验和终点

    • 盘后报告 (FAERS)

观看介绍视频

Make informed decisions to increase the success of regulatory submissions

Female professional talking to colleague

Minimize regulatory cycling and avoid failing approval with PharmaPendium.

  • Discover complete regulatory packages from the EMA and FDA, and FDA Advisory Committee Meeting Documents

  • Explore previous regulatory submissions and learn from precedents to predict agencies’ requirements

  • Benchmark against approved and withdrawn drugs with the same mechanism of action as your drug candidates

  • Rapidly respond to regulatory questions using comparative data from FDA/EMA drug approval and review documents

Analyze the toxicity of drug candidates and advance the 3Rs with the new Tox Navigator

Developed in collaboration with Pfizer, Tox Navigator includes toxicity data from regulatory documents and scientific articles.

Supporting the 3Rs and patient safety assessment, the Tox Navigator helps you:

  • Convert animal doses to human equivalent doses (HEDs)

  • Leverage existing data to reduce number of animal studies and design more efficient studies

  • Investigate adverse drug reactions across different species

  • Integrate in silico models and other non-animal testing methods

  • Optimize research efforts by focusing on candidates with favorable safety profiles

Connected, configurable solutions to innovate in R&D

Advance your research with Elsevier’s PharmaPendium and a portfolio of solutions for pharmaceutical R&D.

Innovate with confidence, supported by:

  • Trusted quality information from regulatory data to peer-reviewed scientific literature

  • Innovative technology that powers data transformation, and analytical and predictive tools

  • Domain and data science expertise to solve complex problems with data solutions for R&D

Information integrity is essential to your progress. Discover trusted data and tools that deliver critical insights.

Let's shape progress together.

Find precise data to advance your drug portfolio

DDI risk calculator picto

FDA 和 EMA 文件

利用 PharmaPendium 的强大功能,提供完整的 FDA 和 EMA 批准包以及重要的 FDA 咨询委员会会议文件,这是其他工具所无法比拟的。
Efficacy data picto

Enhanced visualization

Seamlessly move from table view to interactive charts, graphs and visual aids to easily interrogate and interpret data.
Predictive model picto

Predictive tools

Predict harmful DDIs using the DDI Risk Calculator and the risk of off-target adverse events using the Safety Margin Tool.
Cultivate curiosity picto

无与伦比的搜索功能

使用标准化数据按不良事件 (MedDRA)、靶点、适应症、药物和终点查找信息。结果页面弥合了临床前和临床的鸿沟。
Reference picto

来自 FAERS 的真实世界证据

在 FAERS(FDA 不良事件报告系统)中搜索超过 1900 万份报告,从真实世界证据和上市后药物安全性中查找任何不良事件。
Data management picto

高质量数据集

PharmaPendium 的高质量数据集可供平台外使用。将数据嵌入到您的工作流程和模型中,以实现更准确的搜索和预测。
... PharmaPendium 擅长检索按药物和物种分类的批准文件中的特定毒性观察结果。
Guy Bouvier

Guy Bouvier, PhD, ERT

Groupe Pierre Fabre 的 Director, Toxicology & Product Safety

Frequently asked questions

PharmaPendium Support Center

Get comprehensive data and innovative tools to analyze drug safety, deliverability and efficacy

Business people in meeting